John M. Feigert
Impact in
- Hematology top 5%
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Hemoglobinopathies and Related Disorders
Papers in
-
- Iron Metabolism and Disorders 4
- Acute Myeloid Leukemia Research 3
- Platelet Disorders and Treatments 2
- Genetics 2
- Hemoglobinopathies and Related Disorders 2
- Co-authors
- David P. Steensma (4 shared papers)Azra Raza (4 shared papers)Jason Esposito (4 shared papers)Alan F. List (4 shared papers)Emmanuel C. Besa (4 shared papers)Maria R. Baer (4 shared papers)Carole S. Paley (4 shared papers)Chao Yin (1 shared paper)
- Journals
- Blood (4 papers)Annals of Internal Medicine (1 paper)Journal of Clinical Oncology (1 paper)Cancer Investigation (1 paper)Journal of Oncology Practice (1 paper)
- Partner nations
- United States
In The Last Decade
John M. Feigert
10 papers receiving 354 citations
Peers
Comparison fields: 5 of 32
- Hematology 286
- Genetics 77
- Oncology 42
- Biochemistry 11
- Toxicology 4
Countries citing papers authored by John M. Feigert
This map shows the geographic impact of John M. Feigert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Feigert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Feigert more than expected).
Fields of papers citing papers by John M. Feigert
This network shows the impact of papers produced by John M. Feigert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Feigert. The network helps show where John M. Feigert may publish in the future.
Co-authors
The 8 scholars most cited alongside John M. Feigert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 155 | |
| 2 | 2015 | 65 | |
| 3 | 1998 | 49 | |
| 4 | 1990 | 35 | |
| 5 | 2008 | 26 | |
| 6 | 2007 | 21 | |
| 7 | 2009 | 13 | |
| 8 | 2010 | 5 | |
| 9 | 2013 | 3 | |
| 10 | 2019 | 3 |
About John M. Feigert
John M. Feigert is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Health Information Management, having authored 10 papers that have together received 375 indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (4 papers), Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Platelet Disorders and Treatments (2 papers), Healthcare Policy and Management (1 paper), Lymphadenopathy Diagnosis and Analysis (1 paper) and Clinical practice guidelines implementation (1 paper). The work is most often cited by research in Hematology (286 citations), Genetics (77 citations), Oncology (42 citations), Biochemistry (11 citations) and Toxicology (4 citations). John M. Feigert has collaborated with scholars based in United States. Frequent co-authors include David P. Steensma, Azra Raza, Jason Esposito, Alan F. List, Emmanuel C. Besa, Maria R. Baer, Carole S. Paley and Chao Yin. Their work appears in journals such as Blood, Annals of Internal Medicine, Journal of Clinical Oncology, Cancer Investigation and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.